Delivery Order SPE2DB22D3102-SPE2DB25FK9AK

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB22D2005|SPE2DB25FJEP2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,442.47 firm-fixed-price delivery order is for the supply of 4566421092 tablets of the medication KLONOPIN 0.5 MG. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,797.69 delivery order contract is for the supply of 4565843772 KLONOPIN 0.5 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. This award is not designated with any set-aside requirements, indicating open...
This federal contract award, SPE2DB22D3016|SPE2DB25FALC7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.82 Firm Fixed Price Delivery Order covers the supply of 4567027865 KLONOPIN 0.5 MG TABLET 100S, with a performance period through January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,030.36 firm fixed-price delivery order is for the supply of KLONOPIN 0.5 MG TABLET 100S, a medication used to treat certain types of seizures. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award with ID SPE2DB22D2006|SPE2DB24FW0XV was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,804.69 firm fixed-price delivery order is for the supply of 4564837591 Klonopin 1 mg tablets. The contract has an ultimate completion date of June 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,087.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4566637349 - KLONOPIN 1 MG TABLET 100S, a pharmaceutical...
This federal contract award, with an ID of SPE2DB24D2205|SPE2DB25FDYWD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KLONOPIN 0.5 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $1,206.84 and a completion date of February 26, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside...
The federal contract award SPE2DX15D3002|SPE2DX24F9MY0 was made to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,712.52 firm fixed price delivery order is for the provision of 4564591529 ! KLONOPIN 0.5 MG TABLET 100S to the Defense Department's Medical Supply Chain. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the Defense...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Klonopin 0.5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $1,938.80 and an Ultimate Completion Date of September 25, 2024. The contract is not set aside for any special program. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,300.46 firm fixed price delivery order is for the supply of 4565546861 units of the prescription drug Klonopin (0.5 mg tablets) with a completion date of August 23, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9AK
    Delivery Order

This federal contract award (SPE2DB22D3102|SPE2DB25FK9AK) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.02 Firm Fixed Price delivery order contract is for the supply of KLONOPIN 0.5 MG TABLET 100S, a pharmaceutical product. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:33 PM